Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2002 Nov 23;325(7374):1188.
doi: 10.1136/bmj.325.7374.1188.

The changed image of botulinum toxin

V Peter Misra
Editorial

The changed image of botulinum toxin

V Peter Misra. BMJ. .
No abstract available

PubMed Disclaimer

References

    1. Jost WH, Kohl A. Botulinum toxin: evidence-based criteria in rare indications. J Neurol. 2001;248 suppl1:39–44. - PubMed
    1. Poewe W, Entner T. Studies with Dysport® in cervical dystonia. In: Brin MF, Jankovic J, Hallett M, editors. Scientific and therapeutic aspects of botulinum toxin. Lippincott Williams and Wilkins, Philadelphia. 2002. pp. 365–369.
    1. Klein AW. Complications and adverse reactions with the use of botulinum toxin. Dis Mon. 2002;48:336–356. - PubMed
    1. Carruthers JA, Lowe NJ, Menter MA, Gibson J, Nordquist M, Mordaunt J, et al. A multicenter, double-blind, randomized, placebo-controlled study of the efficacy and safety of botulinum toxin type A in the treatment of glabellar lines. J Am Acad Dermatol. 2002;46:840–849. - PubMed
    1. Lowe NJ, Yamauchi PS, Lask GP, Patnaik R, Iyer S. Efficacy and safety of botulinum toxin type a in the treatment of palmar hyperhidrosis: a double-blind, randomized, placebo-controlled study. Dermatol Surg. 2002;28:822–827. - PubMed

Publication types

MeSH terms